PPARδ comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-04-08. Where a claim depends on a specific study, the study is described rather than over-claimed.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ | Nuclear receptor; not androgen receptor |
| Studied indications | Dyslipidemia; obesity; diabetes | Early clinical research; development discontinued |
| Rodent toxicity | Tumor formation in multiple tissues | Dose-dependent findings in some studies |
| Human approval | None | No approved therapeutic use |
| Typical analytical method | LC-MS/MS | Used for identity and quantification |
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
=== Clinical attachment level === The clinical attachment level (CAL) combines the measurements of probing pocket depth and any gingival recession to give an overall indication of where the periodontal tissues attach to the root surface. It is measured from a constant reference point, usually the CEJ, to the base of the periodontal pocket. Due to the more stable and reproducible property, this is considered the best measure of changes in residual periodontal support over time.
== Plasma vs. serum in medical diagnostics == Plasma and serum are both derived from full blood, but serum is obtained by removing blood cells, fibrin clots, and other coagulation factors while plasma is obtained by only removing blood cells. Blood plasma and blood serum are often used in blood tests. Tests can be done on plasma, serum or both. In addition, some tests have to be done with whole blood, such as the determination of the amount of blood cells in blood via flow cytometry.
==== February ==== On 1 February, the Syrian government forces launched attacks toward Suwayda from the areas of Tal Hadid, Mansoura and Walgha, with four mortar shells. Clashes were reported between the National Guard and the Syrian government forces in the area of Mansour and the National Guard declared that it shot down a drone belonging to the Syrian government forces. A Syrian security source reported an attempted infiltration by what it called "outlaw gangs" in the area of Mansoura. On 2 February, the Syrian internal security forces arrested Nasser Faisal Al-Saadi, a member of the National Guard, Eagles of the Whirlwind and Hezbollah, in addition to being the "biggest drug dealer in the region". On 6 February, the Syrian government forces advanced towards the towns of Atil and Salim, reaching Sweida. A Syrian security source reported attacks toward al-Mazra'a. The Syrian government forces launched attacks toward al-Majdal with rocket launchers, killing the civilian Rani Basel Naeem. On 7 February, a Syrian internal security force member shot and killed four people in Al-Matouna, a rural area of Suwayda, and was later arrested by Syrian government forces. The civilians were harvesting olives before they were shot and had received a security clearance from the government to enter their land. On 10 February, the National Guard denied having closed the road between Umm al-Zaytoun and Damascus, declaring it as "misleading and false information" and that the crossing is controlled by Internal Security Forces in Suwayda.
Newborn screening is intended as a public health program to identify infants with treatable conditions before they present clinically, or suffer irreversible damage. Phenylketonuria (PKU) was the first disorder targeted for newborn screening, being implemented in a small number of hospitals and quickly expanding across the United States and the rest of the world. After the success of newborn screening for PKU (39 infants were identified and treated in the first two years of screening, with no false negative results), Guthrie and others looked for other disorders that could be identified and treated in infants, eventually developing bacterial inhibition assays to identify classic galactosemia and maple syrup urine disease. Newborn screening has expanded since the introduction of PKU testing in the 1960s, but can vary greatly between countries. In 2011, the United States screened for 54 conditions, Germany for 12, the United Kingdom for 2 (PKU and medium chain acyl-CoA dehydrogenase deficiency (MCADD)), while France and Hong Kong only screened for one condition (PKU and congenital hypothyroidism, respectively). The conditions included in newborn screening programs around the world vary greatly, based on the legal requirements for screening programs, prevalence of certain diseases within a population, political pressure, and the availability of resources for both testing and follow-up of identified patients.
== History == The Tetra Brik package was introduced in 1963, after a long process of development and built on the previous Tetra Classic tetrahedron package that laid the foundation for Tetra Pak. Despite the revolutionary character of the new retail system, by the end of the 1950s Ruben Rausing and the Tetra Pak management team realised that the Tetra Pak package portfolio needed to be supplemented by an additional rectangular model to continue to be competitive. Large amounts were spent on development, and in 1963 the first Tetra Brik packaging machine was installed in Motala in central Sweden. Due to its effective use of space and materials and the increased efficiency in distribution and storage that resulted from the rectangular shape, the Tetra Brik soon became Tetra Pak's best seller in Sweden and internationally and paved the way for Tetra Pak's enormous success during the 1970s and onwards. The Tetra Brik package family has since been extended and is currently composed of Tetra Brik and Tetra Brik Aseptic in the shapes Base, Square and Edge, ranging from volumes of 80 to 2000 ml and with a number of different caps. Tetra Brik has been distinguished as one of the 20th century's design icons. It featured in the 2004 Museum of Modern Art New York exhibition Humble Masterpieces and in the 2011 London Science Museum/Vitra Design Museum exhibition Hidden Heroes – The Genius of Everyday Things. It is now part of the permanent collection at the MoMA in New York.
Sources: en.wikipedia.org
=== Italy === The Italian Armed Forces use the "Razione Viveri Speciali da Combattimento", consisting of a heavy duty brownish-green plastic bag with three thin white cardboard cartons inside (one for breakfast, one for lunch and one for dinner), each containing meal items plus accessories. There are seven menus, called "modules", identified by colors: yellow, red, grey, green, white, pink and blue. Typically, breakfast consists of: a chocolate bar, fruit candy, crackers or sweet bread, instant coffee, sugar, and a tube of sweetened condensed milk. Lunch has: two pull-ring cans with precooked foods (Tortellini al Ragù, Pasta e Fagioli, Wurstel, Tacchino in Gelatina, Insalata di Riso, etc.), a small can of fruit cocktail, a multivitamin tablet, energy and fiber tablets, instant coffee, sugar, and a plastic spoon wrapped with a napkin. Dinner consists of two more meal cans plus crackers, an energy bar, instant coffee, and sugar. Accessories are: a folding stove, fuel tablets, water purification tablets, toothpick, matches, and three small disposable toothbrushes with pre-applied tooth powder.
The Germans tried to sway the voters in the area before the plebiscite by using violence, with Polish organisations and activists being harassed by pro-German militias. Actions included murder, the most notable example being the killing of Bogumił Linka, a native Masurian member of the Polish delegation to Versailles, who supported voting for Poland. His death described as "bestial murder" after he had been beaten to death by pro-German militias armed with crowbars, metal rods, and shovels. His ribs were punctured by shovel, and he was taken to hospital, where he died after he had been barely alive and bled from the neck and the head. After his burial, the grave of Linka was defiled. Masurians who supported voting for Poland were singled out and subjected to terror and repressions. Names of Masurians supporting the Polish side were published in pro-German newspapers, and their photographs were presented in shops of pro-German owners. Later, regular hunts were organised after them. In the pursuit of Polish supporters, the local Poles were terrorized by pro-German militias. The "Gazeta Olsztyńska" wrote, "Unspeakable terror lasted till the last days [of the plebiscite]". At least 3,000 Warmian and Masurian activists engaged for Poland had to flee the region for fear of their lives. The German police engaged in active surveillance of the Polish minority and attacks against pro-Polish activists.
retrogene A gene or other DNA sequence which has arisen in a genome by the stable integration of the genetic material of a retrovirus, e.g. by the reverse transcription of viral RNA and the subsequent insertion of the resulting DNA fragments into the host cell's genomic DNA. These endogenous viral elements can then be replicated along with the host's own genes and thus persist indefinitely in the host genome, and in many cases retain the ability to produce functional viral proteins from this latent state, by which they may continue to copy, excise, and/or transpose themselves.
where arg(x,y) is the clockwise angle between the X-axis and the vector (x,y); a function that is available in many programming languages as atan2(y,x). Conversely, given c and α, one can get the type (n,m) by the formulas:
This type of specificity is sensitive to the substrate's optical activity of orientation. Stereochemical molecules differ in the way in which they rotate plane polarized light, or orientations of linkages (see alpha, beta glycosidic linkages). Enzymes that are stereochemically specific will bind substrates with these particular properties. For example, beta-glycosidase will only react with beta-glycosidic bonds which are present in cellulose, but not present in starch and glycogen, which contain alpha-glycosidic linkages. This is relevant in how mammals are able to digest food. For instance, the enzyme Amylase is present in mammal saliva, that is stereo-specific for alpha-linkages, this is why mammals are able to efficiently use starch and glycogen as forms of energy, but not cellulose (because it is a beta-linkage).
Sources: en.wikipedia.org
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.
Rodent studies found dose-dependent tumors in several organs. The sponsor discontinued the program over cancer concerns. Human risk from long-term use remains unknown.
Controlled human endurance trials are lacking. Animal studies show increased exercise capacity under some conditions. Anecdotal reports are not equivalent to clinical evidence.
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.